reboxetine has been researched along with alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid in 1 studies
Studies (reboxetine) | Trials (reboxetine) | Recent Studies (post-2010) (reboxetine) | Studies (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) | Trials (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) | Recent Studies (post-2010) (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) |
---|---|---|---|---|---|
626 | 193 | 184 | 2,899 | 11 | 609 |
Protein | Taxonomy | reboxetine (IC50) | alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (IC50) |
---|---|---|---|
Glutamate receptor 1 | Rattus norvegicus (Norway rat) | 0.157 | |
Glutamate receptor 2 | Rattus norvegicus (Norway rat) | 0.1765 | |
Glutamate receptor 3 | Rattus norvegicus (Norway rat) | 0.1765 | |
Glutamate receptor 4 | Rattus norvegicus (Norway rat) | 0.1765 | |
Glutamate receptor 1 | Mus musculus (house mouse) | 0.04 | |
Glutamate receptor 2 | Mus musculus (house mouse) | 0.04 | |
Glutamate receptor 1 | Homo sapiens (human) | 0.1353 | |
Glutamate receptor 2 | Homo sapiens (human) | 0.1353 | |
Glutamate receptor 3 | Homo sapiens (human) | 0.1353 | |
Glutamate receptor 4 | Homo sapiens (human) | 0.1353 | |
Glutamate receptor 4 | Mus musculus (house mouse) | 0.04 | |
Glutamate receptor 3 | Mus musculus (house mouse) | 0.04 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barbiero, VS; Longordo, F; Luccini, E; Pittaluga, A; Popoli, M; Racagni, G; Raiteri, L; Raiteri, M | 1 |
1 other study(ies) available for reboxetine and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
Article | Year |
---|---|
Antidepressant treatments and function of glutamate ionotropic receptors mediating amine release in hippocampus.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amines; Animals; Antidepressive Agents; Corpus Striatum; Drug Interactions; Excitatory Amino Acid Agents; Fluoxetine; Gene Expression; Hippocampus; Male; Morpholines; N-Methylaspartate; Potassium; Rats; Rats, Sprague-Dawley; Reboxetine; Receptors, Glutamate; Synaptosomes; Time Factors; Tritium | 2007 |